Vertex Systems Deploys Several of UGS’ D-Cubed Software Components in its Architectural CAD Product

UGS Corp., a leading global provider of product lifecycle management (PLM) software and services, and Vertex Systems of Tampere, Finland, today announced that Vertex has integrated the D-Cubed 2D and 3D Dimensional Constraint Manager and Collision Detection Manager software components – part of UGS’ PLM Components family of solutions – in the current release of its Vertex Building Design product line for the architecture, engineering and construction (AEC) industry.

“More and more AEC software vendors are looking to UGS’ PLM Components as the source of key technologies to support an industry shift to sophisticated, parametrically driven, solid and surface modeling techniques, particularly in view of the trend towards the building information modeling (BIM) approach,” said Bruce Feldt, vice president of Open Tools for UGS. “Our PLM Components, proven in the mechanical field, have much to offer the latest generation of AEC applications. The ability of software developers such as Vertex Systems to reuse our PLM Components to drive revenues in multiple product lines, across different markets, is a strong endorsement of the software component business model.”

Vertex Building Design is a software application for timber and steel framers, modular builders, structural insulated panel builders and prefabricated home manufacturers. It combines 3D design with traditional procedures based on 2D plans. The use of 3D modeling has multiple benefits including the creation of sales materials that have greater impact as well as dimensional accuracy. These components have also been integrated into the Vertex Systems mechanical CAD application, Vertex G4, since 2001.

“By applying several of the D-Cubed components in our new software domain, we have enhanced the design productivity of our Vertex Building Design customers and accomplished this with great efficiency,” said Reijo Havonen, president of Vertex Systems. “As we expose more and more of the features of these components over the coming releases, our customers will be able to design their buildings faster and better than ever before.”

About PLM Components and D-Cubed

UGS’ PLM Components are open software tools designed to promote industry standardization and interoperability within the product lifecycle management (PLM) market. Many of the world’s leading CAD/CAM/CAE/PLM vendors have adopted the widely respected solutions from PLM Components for integration into their applications. DCubedTM software is part of the PLM Components suite of solutions and represents a family of geometric software components that enable key functionality in CAD, CAM, CAE, and PLM applications, including sketching, part and assembly modeling, motion simulation, collision detection, clearance measurement and hidden-line visualization. D-Cubed also provides consultancy based software integration services in support of the PLM Open vision. For more information, please visit www.ugs.com/products/open/.

About Vertex Systems Oy

Vertex Systems is an internationally operating provider of highly efficient engineering software products for technical design and data management. Vertex provides high quality Computer Aided Design solutions together with extensive custom development, implementation and consulting services to improve the productivity and profitability of the client. Vertex’s integrated software applications allow the customers to automate their complete product design and information processes. Vertex solutions are based on open software and database architecture with flexible tools for tailoring the system to the customer's specific needs and for integration with other information systems.

Note: UGS, D-Cubed and Transforming the process of innovation are trademarks or registered trademarks of UGS Corp. or its subsidiaries in the United States and in other countries. All other trademarks, registered trademarks or service marks belong to their respective holders.

The statements in this news release that are not historical statements, including statements regarding expected benefits of the product, adoption by customers, continued innovation and other statements identified by forward looking terms such as „may,“ „will,“ „expect,“ „plan,“ „anticipate“ or „project,“ are forward-looking statements. These statements are subject to numerous risks and uncertainties which could cause actual results to differ materially from such statements, including, among others, risks relating to developments in the PLM industry, competition, failure to innovate, partnering strategy, major design errors or security flaws and intellectual property. UGS has included a discussion of these and other pertinent risk factors in its quarterly report on Form 10-Q for the period ended June 30, 2006 filed with the SEC. UGS disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Jim Thorpe
UGS
+44 1223 722 655
jim.thorpe@ugs.com
Reijo Havonen
Vertex Systems
+358 3 313411
reijo.havonen@vertex.fi

Media Contact

Weitere Informationen:

http://www.ugs.com/products/open/

Alle Nachrichten aus der Kategorie: Unternehmensmeldungen

Zurück zur Startseite

Kommentare (0)

Schreiben Sie einen Kommentar

Neueste Beiträge

Sensoren für „Ladezustand“ biologischer Zellen

Ein Team um den Pflanzenbiotechnologen Prof. Dr. Markus Schwarzländer von der Universität Münster und den Biochemiker Prof. Dr. Bruce Morgan von der Universität des Saarlandes hat Biosensoren entwickelt, mit denen…

3D-Tumormodelle für Bauchspeicheldrüsenkrebsforschung an der Universität Halle

Organoide, Innovation und Hoffnung

Transformation der Therapie von Bauchspeicheldrüsenkrebs. Bauchspeicheldrüsenkrebs (Pankreaskarzinom) bleibt eine der schwierigsten Krebsarten, die es zu behandeln gilt, was weltweite Bemühungen zur Erforschung neuer therapeutischer Ansätze anspornt. Eine solche bahnbrechende Initiative…

Leuchtende Zellkerne geben Schlüsselgene preis

Bonner Forscher zeigen, wie Gene, die für Krankheiten relevant sind, leichter identifiziert werden können. Die Identifizierung von Genen, die an der Entstehung von Krankheiten beteiligt sind, ist eine der großen…